Familial Mediterranean Fever; Recent Advances, Future Prospectives

Recent Advances Group

Diagnostics · 2025

Grade Bnarrative review

Key Findings

  • JAK inhibitors (tofacitinib) showing promise in case series
  • Updated pipeline of emerging therapies

Referenced in (1 disease)

ID: pmid-40218163PMID: 40218163